Agenus
AGEN----
Agenus (AGEN)
Agenus Inc., a clinical-stage biotechnology company, discovers and develops immunotherapies for cancer and infectious diseases in the United States and internat...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Agenus Analyst Rating
View MoreForecast & Rating
Jul 13, 2026Price forecast
$30.00401.67%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · 1 day ago, 10:24 PM
Top Biotech Gainers: ADVB Soars Over 200% In A Week, NVCR, MEDP Report Q2 Results, AGMB In Focus
- StockTitan · Jul 17 at 01:28 AM
Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026 | AGEN Stock News
- benzinga_article · Jul 14 at 10:37 AM
Why Is Agenus Stock Falling on Tuesday?
- rttnews · Jul 13 at 09:35 PM
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus
- benzinga_article · Jul 13 at 08:34 PM
Oracle, Twin Vee PowerCats, Agenus, Micron Technology and SanDisk: Why These 5 Stocks Are on Investors' Radars Today
- Quartr · Jul 13 at 06:04 AM
AGEN: Secured $340M to advance Phase 3 BOT + BAL trial in MSS colon cancer, targeting major market
